Similar Posts
Is Active Surveillance the Right Course For Men with Prostate Cancer?
Prostate-specific antigen (PSA) testing of middle-age men to screen for prostate cancer has led to more cases being detected at an early stage. The common occurrence of prostate cancer indicates that many of these men will die with prostate cancer rather than of the disease. “We recognize that anywhere from 30 to 50 percent of…
Should I Do A Multiparametric MRI Before Having A Prostate Biopsy?
In medicine, change sometimes happens with two steps forward but one step back. For example, in the early 20th century, delivering babies in hospitals became more popular than home births in order to have “painless” births with anesthesia. However, for many women the higher complication and infection rates proved to be a setback. Thankfully, problems…
Fewer Men Seem To Die After Prostate Surgery than Radiation
When men with prostate cancer need to choose a treatment option, it’s helpful to have information that compares and contrasts the different therapies. Now a first-of-its-kind study has compared two of those treatment choices and found that prostate surgery (prostatectomy) yields better survival than external beam radiation therapy (EBRT). In particular, the study examined robotic…
How Do Fusion Genes Promote Prostate Cancer?
Among the many mysteries surrounding prostate cancer has been one involving fusion genes in prostate cancer cells that has a role in promoting cancer growth, but no one has known how it works. Now researchers at Weill Cornell Medical College have discovered a gene mutation in these cells and how it works to turn abnormal cell…
How To Get Provenge for Prostate Cancer
If you have advanced prostate cancer that has not responded to hormonal therapy (castration-resistant prostate cancer), you be wondering whether to try Provenge for your cancer. Provenge is a novel treatment for advanced prostate cancer that is made by Dendreon. Rather than a chemotherapy or hormone therapy, Provenge is an immunotherapy. This means that Provenge helps…
Xofigo Compared to Zytiga for Prostate Cancer Treatment
Xofigo compared to Zytiga means that men with prostate cancer have another treatment option to consider. The Food and Drug Administration (FDA) approved a new medication, Xofigo (radium-223 dichloride), for late stage (metastatic) castration-resistant prostate cancer on May 15, 2013. With this new medication addition to the market, prostate cancer patients will want to ask…